Tagrisso 80 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FM45Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,876
Award facts
- Contract value 100% obligated
- $24,876.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, through its parent company Cencora, Inc., received a delivery order award from the Defense Logistics Agency (DLA) on January 26, 2026, for the supply of Tagrisso 80 mg tablets (30-count packages) valued at $24,876.30. This firm fixed-price, non-set-aside contract is set to complete by February 17, 2026, with performance conducted at Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. The award represents a task order issued under the company's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026 (recently extended through December 2031 under Cencora's parent-level IDC), which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
Tagrisso is a brand-name oncology medication used for non-small cell lung cancer treatment, reflecting Amerisourcebergen's established role as a critical pharmaceutical distributor for federal medical procurement needs. The company's extensive contract history with DLA demonstrates its capability to deliver a diverse portfolio of medications, vaccines, and medical supplies across multiple therapeutic domains to support military treatment facilities and other government healthcare systems. This delivery order exemplifies routine pharmaceutical procurement activities under the larger strategic DLA medical supply framework, which supports the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities.
Quick answers
Who was awarded contract SPE2DR26FM45Y?
SPE2DR26FM45Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FM45Y worth?
The government has obligated $24,876 on SPE2DR26FM45Y.
Is contract SPE2DR26FM45Y an order under another contract?
Yes. SPE2DR26FM45Y is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM45Y competed?
The extent of competition for SPE2DR26FM45Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award